Novo CEO signals M&A opportunities to strengthen drug pipeline

The True Post icon

Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.

Source: CNBC

Share This Article
The newsroom of The True Post.
Leave a Comment